Arcadia Biosciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US0390143032
USD
1.70
0 (-0.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
LSB Industries, Inc.
Oil-Dri Corp. of America
American Vanguard Corp.
Arcadia Biosciences, Inc.
China Green Agriculture, Inc.
Piedmont Lithium, Inc.
CVR Partners LP
Scotts Miracle-Gro Co.
Bioceres Crop Solutions Corp.
Snow Lake Resources Ltd.
Yield10 Bioscience, Inc.

Why is Arcadia Biosciences, Inc. ?

1
Poor Management Efficiency with a low ROE of 0.98%
  • The company has been able to generate a Return on Equity (avg) of 0.98% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
  • NET PROFIT(HY) At USD -4.61 MM has Grown at -700.78%
  • CASH AND EQV(HY) Lowest at USD 10.33 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -45.86%, its profits have risen by 6.6%
4
Below par performance in long term as well as near term
  • Along with generating -45.86% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Arcadia Biosciences, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Arcadia Biosciences, Inc.
-45.89%
-0.40
100.06%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
31.40%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
-16.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
0.60
Tax Ratio
1.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.99%
ROCE (avg)
0
ROE (avg)
0.98%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.56
EV to EBIT
0.32
EV to EBITDA
0.33
EV to Capital Employed
2.84
EV to Sales
-0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
889.80%
ROE (Latest)
-90.89%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -6.09 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.81 times

DEBT-EQUITY RATIO (HY)

Lowest at -108.12 %

PRE-TAX PROFIT(Q)

Highest at USD 0.3 MM

NET PROFIT(Q)

Highest at USD 0.3 MM

-10What is not working for the Company
NET PROFIT(HY)

At USD -4.61 MM has Grown at -700.78%

CASH AND EQV(HY)

Lowest at USD 10.33 MM

Here's what is working for Arcadia Biosciences, Inc.

Operating Cash Flow
Highest at USD -6.09 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Pre-Tax Profit
At USD 0.3 MM has Grown at 117.55%
over average net sales of the previous four periods of USD -1.69 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 0.3 MM has Grown at 117.53%
over average net sales of the previous four periods of USD -1.69 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 2.81 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Pre-Tax Profit
Highest at USD 0.3 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 0.3 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Debt-Equity Ratio
Lowest at -108.12 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Arcadia Biosciences, Inc.

Cash and Eqv
Lowest at USD 10.33 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents